The Law Offices of Frank R. Cruz continues its investigation of Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT) on behalf of investors concerning the Company’s possible violations of federal securities laws.
If you are a shareholder who suffered a loss, click here to participate.
On October 4, 2021, Owlet revealed that it had received a warning letter from the U.S. Food and Drug Administration (“FDA”), which stated that “the Company’s marketing of its Owlet Smart Sock product . . . renders [it] a medical device …
Full story available on Benzinga.com
Original Post: benzinga.com